ACBYX
Price
$15.39
Change
+$0.03 (+0.20%)
Updated
Jul 3 closing price
Net Assets
106.71M
CLBAX
Price
$36.80
Change
+$0.18 (+0.49%)
Updated
Jul 3 closing price
Net Assets
252.39B
Interact to see
Advertisement

ACBYX vs CLBAX

Header iconACBYX vs CLBAX Comparison
Open Charts ACBYX vs CLBAXBanner chart's image
American Beacon Balanced Y
Price$15.39
Change+$0.03 (+0.20%)
VolumeN/A
Net Assets106.71M
American Funds American Balanced 529A
Price$36.80
Change+$0.18 (+0.49%)
VolumeN/A
Net Assets252.39B
ACBYX vs CLBAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ACBYX vs. CLBAX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACBYX is a Buy and CLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CLBAX has more cash in the bank: 252B vs. ACBYX (107M). CLBAX (1.84) and ACBYX (1.80) have matching dividends . ACBYX was incepted earlier than CLBAX: ACBYX (15 years) vs CLBAX (23 years). ACBYX (0.94) is less costly to investors than CLBAX (0.58). CLBAX is a more actively managed with annual turnover of: 44.00 vs. ACBYX (38.00). CLBAX has a lower initial minimum investment than ACBYX: CLBAX (250) vs ACBYX (100000). CLBAX annual gain was more profitable for investors over the last year : 7.84 vs. ACBYX (3.06). CLBAX return over 5 years is better than : 43.26 vs. ACBYX (18.40).
ACBYXCLBAXACBYX / CLBAX
Total Expense Ratio0.940.58162%
Annual Report Gross Expense Ratio0.940.58162%
Fund Existence15 years23 years-
Gain YTD5.6118.07370%
Front LoadN/A4%-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets107M252B0%
Annual Yield % from dividends1.801.8498%
Returns for 1 year3.067.8439%
Returns for 3 years14.6436.1440%
Returns for 5 years18.4043.2643%
Returns for 10 years8.8577.5511%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNET7.750.67
+9.46%
VNET Group
DGICB17.31N/A
N/A
Donegal Group
EMCG12.15N/A
N/A
Embrace Change Acquisition Corp
WINT0.77N/A
N/A
Windtree Therapeutics Inc.
SCI81.78-0.40
-0.49%
Service Corp